Cargando…
Pirin: a potential novel therapeutic target for castration‐resistant prostate cancer regulated by miR‐455‐5p
Androgen deprivation therapy is frequently used to treat prostate cancer (PCa), but resistance can occur, a condition known as castration‐resistant prostate cancer (CRPC). Thus, novel approaches for identification of CRPC are important for designing effective PCa treatments. Analysis of microRNA (mi...
Autores principales: | Arai, Takayuki, Kojima, Satoko, Yamada, Yasutaka, Sugawara, Sho, Kato, Mayuko, Yamazaki, Kazuto, Naya, Yukio, Ichikawa, Tomohiko, Seki, Naohiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360383/ https://www.ncbi.nlm.nih.gov/pubmed/30444038 http://dx.doi.org/10.1002/1878-0261.12405 |
Ejemplares similares
-
Anti-tumor roles of both strands of the miR-455 duplex: their targets SKA1 and SKA3 are involved in the pathogenesis of renal cell carcinoma
por: Yamada, Yasutaka, et al.
Publicado: (2018) -
Impact of novel oncogenic pathways regulated by antitumor miR‐451a in renal cell carcinoma
por: Yamada, Yasutaka, et al.
Publicado: (2018) -
Regulation of antitumor miR‐144‐5p targets oncogenes: Direct regulation of syndecan‐3 and its clinical significance
por: Yamada, Yasutaka, et al.
Publicado: (2018) -
Regulation of NCAPG by miR‐99a‐3p (passenger strand) inhibits cancer cell aggressiveness and is involved in CRPC
por: Arai, Takayuki, et al.
Publicado: (2018) -
Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer
por: Goto, Yusuke, et al.
Publicado: (2017)